Does everyone remember the discussion of the PR wh
Post# of 148106
“”On the call, NP drew a distinction between “Commercialization” of LL, which means: labeling, advertising and selling the drug retail, versus charging for equipping hospitals with a supply to provide CSP at various hospitals on a large scale, at their discretion, throughout the Philippines. There is a difference here. Let’s let this play out and see if there is truth in NP. I do not see how he can survive, as CEO, if this is not a significant milestone.””